Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Limited has issued an update to correct an auto-correction error in their previous buy-back notification. The update pertains to the ordinary fully paid shares under the ASX code ACL. The buy-back remains an on-market transaction, and this announcement serves as a clarification to the market.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.